Purdue develops next-generation platform to accelerate cancer drug discovery

A New Cancer Drug and the Nature of Scientific Discovery

Cancer treatments have improved markedly over the past twenty years, largely because of the incremental nature of scientific discovery.

Purdue develops next-generation platform to accelerate cancer drug discovery

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to dramatically accelerate one of the slowest and most challenging stages of cancer drug discovery: identifying promising compounds that could eventually become new therapies.